RxDoctor Payments Data

Elicia Hinton

Family · Phoenix, AZNPI 1922644012

Payments from drug & device makers

$641in general payments, 2019–2025

Across 35 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$131
  • Bayer$64
  • Lilly USA, LLC$52
  • Biohaven Pharmaceuticals, Inc.$49
  • Xeris Pharmaceuticals, Inc.$43
  • Protega Pharmaceutials Inc$35
  • plus $267 from 12 others

What the payments were for

  • Food & beverage$641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$641 in reported general payments places this provider in the 60th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$12,052
Medicare patients
96
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide99$117,046
JardianceEmpagliflozin84$78,872
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$16,844
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,369
LantusInsulin Glargine,hum.Rec.Anlog15$1,901
Albuterol Sulfate HfaAlbuterol Sulfate89$1,593
Gabapentin64$1,169
Fluticasone Propionate46$1,158
Omeprazole57$1,153
Atorvastatin Calcium97$733
Etodolac12$662
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav57$635
Metformin Hcl91$633
Losartan Potassium66$599
Lisinopril91$485

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$52$117,04699 claims
Boehringer IngelheimJardiance$131$78,87284 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,119 family providers in Arizona.

Other family in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →